Hepatitis C and the layering of disease-related stigma
In the U.S., hepatitis C virus (HCV) infection affects nearly 4.5 million people, is the leading cause of chronic liver disease, and was the leading cause of infectious disease-related deaths prior to the COVID-19 pandemic. Patients with HCV face significant stigma associated with their diagnosis, but the prevalence and determinants of this stigma have not been examined. In a recent study, researchers explore demographic, clinical, and behavioral factors associated with patients’ experiences of HCV-related stigma.
FULL STORY AT Leonard Davis Institute →